The Clinical and Biochemical Predictors of Bone Mass in Preterm Infants

被引:23
|
作者
Czech-Kowalska, Justyna [1 ]
Czekuc-Kryskiewicz, Edyta [2 ]
Pludowski, Pawel [2 ]
Zaniuk, Katarzyna [3 ]
Jaworski, Maciej [2 ]
Luba, Anna [1 ]
Grzybowska, Karolina [1 ]
Pilat, Krystyna [1 ]
Dobrzanska, Anna [1 ]
机构
[1] Childrens Mem Hlth Inst, Dept Neonatol & Neonatal Intens Care, Warsaw, Poland
[2] Childrens Mem Hlth Inst, Dept Biochem Radioimmunol & Expt Med, Warsaw, Poland
[3] Holy Family Hosp, Dept Neonatol, Warsaw, Poland
来源
PLOS ONE | 2016年 / 11卷 / 11期
关键词
SERUM ALKALINE-PHOSPHATASE; BIRTH-WEIGHT INFANTS; HIGH-TURNOVER OSTEOPENIA; X-RAY ABSORPTIOMETRY; CHRONIC LUNG-DISEASE; DEXAMETHASONE TREATMENT; PREMATURE-INFANTS; GESTATIONAL-AGE; METABOLISM; MINERALIZATION;
D O I
10.1371/journal.pone.0165727
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Metabolic bone disease of prematurity still occurs in preterm infants, although a significant improvement in neonatal care has been observed in recent decades. Dual-energy X-ray absorptiometry (DXA) is the precise technique for assessing bone mineral content (BMC) in preterm infants, but is not widely available. Aim To investigate the clinical and biochemical parameters, including bone metabolism markers as potential predictors of BMC, in preterm infants up to 3 months corrected age (CA). Materials and Methods Ca-P homeostasis, iPTH, 25-hydroxyvitamin D, osteocalcin, N-terminal propeptide, crosslinked C-telopeptide and amino-terminal pro C-type natriuretic peptide and the DXA scans were prospectively performed in 184 preterm infants (<= 34 weeks' gestation) between term age and 3 mo CA. Lower bone mass was defined as BMC below or equal to respective median value for the whole study group, rounded to the nearest whole number. Results The appropriate quality DXA scans were available for 160 infants (87%) examined at term and for 130 (71%) tested at 3 mo CA. Higher iPTH level was the only independent predictor of lower BMC at term, whereas lower BMC at 3 mo CA was associated both with lower urinary phosphate excretion and higher serum osteocalcin level. ROC analysis showed that iPTH >43.6 pg/mL provided 40% sensitivity and 88% specificity in identification of preterm infants with lower BMC at term. In turn, urinary phosphate excretion (TRP>97% or UP/Cr <= 0.74 mg/mg) and serum osteocalcin >172 ng/mL provided 40% sensitivity and 93% specificity in identification of infants with decreased BMC at 3 mo CA. Conclusion Serum iPTH might to be a simple predictor of reduced BMC in preterm infants at term age, but urinary phosphate excretion and serum osteocalcin might predict reduced BMC at 3 mo CA. These results represent a promising diagnostic tool based on simple, widely available biochemical measurements for bone mass assessment in preterm infants.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Arginine deficiency in preterm infants: biochemical mechanisms and nutritional implications
    Wu, GY
    Jaeger, LA
    Bazer, FW
    Rhoads, JM
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2004, 15 (08) : 442 - 451
  • [22] An Integrative Review of Cytokine/Chemokine Predictors of Neurodevelopment in Preterm Infants
    Nist, Marliese Dion
    Pickler, Rita H.
    BIOLOGICAL RESEARCH FOR NURSING, 2019, 21 (04) : 366 - 376
  • [23] Predictors of sustained maternal milk feeds in extremely preterm infants
    Omarsdottir, S.
    Adling, A.
    Bonamy, A. K. E.
    Legnevall, L.
    Tessma, M. K.
    Vanpee, M.
    JOURNAL OF PERINATOLOGY, 2015, 35 (05) : 367 - 372
  • [24] Effect of physical therapy on bone remodelling in preterm infants: a multicenter randomized controlled clinical trial
    Torro-Ferrero, Galaad
    Javier Fernandez-Rego, Francisco
    Rosario Jimenez-Liria, Maria
    Jose Aguera-Arenas, Juan
    Pinero-Penalver, Jessica
    del Mar Sanchez-Joya, Maria
    Jesus Fernandez-Berenguer, Maria
    Rodriguez-Perez, Monica
    Gomez-Conesa, Antonia
    BMC PEDIATRICS, 2022, 22 (01)
  • [25] The Effect of Unadjusted Mineral Supplementation on Bone Health of Preterm Infants Fed Fortified Human Milk: An Exploratory Analysis
    Cardoso, Manuela
    Figueiredo, Leonor
    Moreira-Rosario, Andre
    Camolas, Jose
    Virella, Daniel
    Macedo, Israel
    Pereira-da-Silva, Luis
    JOURNAL OF CLINICAL NEONATOLOGY, 2024, 13 (02) : 48 - 56
  • [26] Metabolic Bone Disease and Bone Mineral Density in Very Preterm Infants
    Figueras-Aloy, Josep
    Alvarez-Dominguez, Enriqueta
    Perez-Fernandez, Jose M.
    Moretones-Sunol, Gloria
    Vidal-Sicart, Sergi
    Botet-Mussons, Francesc
    JOURNAL OF PEDIATRICS, 2014, 164 (03) : 499 - 504
  • [27] Metabolic Bone Disease in preterm newborn: an update on nutritional issues
    Bozzetti, Valentina
    Tagliabue, Paolo
    ITALIAN JOURNAL OF PEDIATRICS, 2009, 35
  • [28] Bone status in preterm infant: influences of different nutritional regimens and possible markers of bone disease
    Meneghelli, M.
    Pasinato, A.
    Salvadori, S.
    Gaio, P.
    Fantinato, M.
    Vanzo, V.
    De Terlizzi, F.
    Verlato, G.
    JOURNAL OF PERINATOLOGY, 2016, 36 (05) : 394 - 400
  • [29] Effects of aggressive parenteral nutrition on growth and clinical outcome in preterm infants
    Can, Emrah
    Bulbul, Ali
    Uslu, Sinan
    Comert, Serdar
    Bolat, Fatih
    Nuhoglu, Asiye
    PEDIATRICS INTERNATIONAL, 2012, 54 (06) : 869 - 874
  • [30] Effects of anaemia on haemodynamic and clinical parameters in apparently stable preterm infants
    Quante, Mirja
    Pulzer, Ferdinand
    Blaeser, Annett
    Gebauer, Corinna
    Kluge, Jens
    Robel-Tillig, Eva
    BLOOD TRANSFUSION, 2013, 11 (02) : 227 - 232